Latest News: Big Data & Analytics
Discover the latest tips, news and insights from Zephyr Health
2018 is the year the Life Sciences must push toward digital transformation. William King, founder and executive chairman of Zephyr Health, looks ahead to new trends and offers five predictions that will be critical for pharma go-to-market strategies.
Big data is dramatically changing how pharma approaches its customers. In this FirstWord webinar and accompanying interview, you’ll discover the key benefits every team can gain from utilizing big data and analytics.
To handle the growing complexity of the healthcare stakeholder ecosystem, commercial teams in the Life Sciences are turning to artificial intelligence and machine learning to save money, integrate data, and reach the right customers.
Networks of relationships are shifting the decision-making process. In this new report, learn how how digital insights on customer networks are critical differentiators for your go-to-market brand initiatives.
Announcing Relationship Analytics: a suite of analytic capabilities designed help to understand and capitalize on HCP and HCO relationships and networks for more effective engagement and decision-making
In this excerpt from Pharmaceutical Executive, we discuss the imperative for pharma to take next steps in tech adoption as we face a new inflection point in the evolution of big data.
In this interview with Pharma Leaders, Zephyr Health President and CEO Lance Scott shares his top 5 things to know about data and insights for Life Sciences companies and their digital transformation strategies.
Medical science liaisons (MSLs) need a wide, objective view of recognized and up-and-coming thought leaders. Integrating different data streams into a single source of the truth provides up-to-date, reliable, and compliant methods of assessing physicians.
At Medforce 2017, Zephyr Health CEO Lance Scott moderated a panel with Abbott’s Megan Oh and Medtronic’s Nathan Phillipp on the power of data and insights. Read our recap to find out their best practices for implementing a big data strategy.
Zephyr Health founder and chairman William King discusses the future of data in Life Sciences with Pharma Leaders, including trends, best practices, the value of insights and analytics, and what to look for in a data partner.
In case you missed it: Don’t get left behind! These three tips will get you out of the starter’s blocks and at the head of the pack when it comes to adopting a big data strategy. The reward is a competitive advantage – the time to act is now!
How blockchain technology could revolutionize the healthcare industry: Zephyr Health founder and executive chairman William King explores blockchain’s security features and potential applications within the Life Sciences.